AKORA Resources Limited (ASX:AKO) Announces $1.293 Million Share Placement and Trading Resumption
AKORA Resources Limited (ASX:AKO) announces a $1.293 million share placement to support strategic investments and trading resumption.
Tag: Corporate Strategy & Guidance
Vmoto Limited (ASX:VMT) Releases 4Q24 Market Update
Vmoto Limited (ASX:VMT) reports a 4Q24 sale of 3,801 units, maintains strong financials, enters new joint ventures, and wins design awards.
Vonex Limited (ASX:VN8) Announces $13.9M Entitlement Offer and CEO Departure
Vonex Limited (ASX:VN8) announces a $13.9M entitlement offer to repay debt and the departure of CEO Ian Porter.
Predictive Discovery Limited (ASX:PDI) Raises A$69M in Strategic Placement
Predictive Discovery Limited (ASX:PDI) raises A$69M in strategic placement to advance its Bankan Gold Project.
Pro Medicus Limited (ASX:PME) Secures A$53M Contract with BayCare
Pro Medicus Limited (ASX:PME) secures a A$53M, 7-year contract with BayCare to implement its Visage 7 Enterprise Imaging Platform.
Australian Gold and Copper Ltd (ASX:AGC) Reports New Copper Exploration Results
Australian Gold and Copper Ltd (ASX:AGC) announces new copper exploration results and identifies additional targets in the Achilles region.
Sarytogan Graphite Limited (ASX:SGA) Updates on Baynazar Copper Exploration
Sarytogan Graphite Limited (ASX:SGA) reports significant progress in its Baynazar copper exploration project, highlighting new anomalies and plans for future drilling.
Intelligent Monitoring Group Limited (ASX:IMB) Secures $122.5M New Debt Facility with NAB
Intelligent Monitoring Group Limited (ASX:IMB) secures a $122.5M debt facility with NAB, reducing interest expenses by $6.5M annually and enhancing financial capacity for acquisitions.
Canyon Resources Limited (ASX:CAY) Approves Inland Rail Facility in Cameroon
Canyon Resources Limited (ASX:CAY) secures approval for Inland Rail Facility in Cameroon, advancing its Minim Martap Bauxite Project.
Rhythm Biosciences Ltd (ASX:RHY) Completes Genetype Integration
Rhythm Biosciences (ASX:RHY) completes Genetype integration, enhancing commercial operations for geneType™ and ColoSTAT® products.